Finland· FI-REL-REL28586
Flavamed
A ambroxol product containing ambroxol hydrochloride, registered in Finland by Berlin-Chemie AG. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ambroxol is registered in 11 of 19 countries.
Countries holding a registration under ATC R05CB06 (ambroxol), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Ambroxol · ATC R05CB06
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Ambroxol hydrochloride
- Manufacturer
- Berlin-Chemie AG
- Country
- Finland (FI)
- ATC code
- R05CB06
- ATC class
- Ambroxol
- Defined daily dose
- 75 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ambroxol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAmbroksol HascoPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- CzechiaAMBROBENEratiopharm GmbH, Ulm
- FranceAMBROXOL ARROW 30 mg, compriméARROW GENERIQUES
- SpainMUCOSAN 30 mg COMPRIMIDOSOpella Healthcare Spain S.L.
- United KingdomMucosolvan 30mg tabletsImported (Italy)
- GermanyAmbrobetaBetapharm Arzneimittel Gmbh
- BelgiumAmbroxine 2,5 mg/doseBoehringer Ingelheim
- SwedenMucoangin Citron 20 mg SugtablettOpella Healthcare France SAS
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Ambrobene, Ambrohexal
- Belgium · Bisolangin
- Bulgaria · Mукосолван Макс, Амбрекс
- Cyprus · Broxivan, Fluibron
- Czechia · Ambrobene, Ambrosan
- Germany · Ambrobeta, Ambrox
- Denmark · Ambroxolhydrochlorid Teva
- Estonia · Ambrolan, Ambrolytin
- Spain · Ambroxol Aldo-Unión, Ambroxol Cinfa
- France · Ambroxol Arrow, Ambroxol Biogaran Conseil
- Greece · Abrobion, Aprinol
- Croatia · Brosils, Flavamed
- Hungary · Ambrobene, Ambrobene Liquid
- Iceland · Broksil
- Italy · Ambrotus, Ambroxol Tecnigen
- Lithuania · Ambrolan, Ambrotusin
- Luxembourg · Ambroxol Hustenlöser Ratiopharm, Ambroxol Hustensaft
- Latvia · Ambroksol, Ambrolan
- Malta · Broncoliber, Broncosil
- Norway · Ambroksolhydroklorid Med Lakrissmak Geiser, Ambroksolhydroklorid Med Mintsmak Geiser
- Poland · Aflegan, Ambroksol Apteo Med
- Portugal · Ambroxol Azevedos, Ambroxol Farmoz
- Romania · Ambromed, Ambroxol Al
- Sweden · Ambroksol Lakrits Geiser, Ambroksol Mint Geiser
- Slovenia · Ambroksolijev Klorid Berlin-Chemie, Ambrospray
- Slovakia · Ambrobene, Ambrobene Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/efb5d146-bf48-4226-9e1a-de4b19d75374 GET /v1/drugs/efb5d146-bf48-4226-9e1a-de4b19d75374?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.12",
"form": "tabletti",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "30 mg",
"atc_label": "ambroksoli",
"ma_number": "23557",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL28586",
"authorised_at": "2007-12-17"
}See everything about ambroxol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.